Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial
…, ED Paskett, T Ahles, LR Bressler, CE Fadul… - Jama, 2013 - jamanetwork.com
Importance There are no known effective treatments for painful chemotherapy-induced
peripheral neuropathy. Objective To determine the effect of duloxetine, 60 mg daily, on average …
peripheral neuropathy. Objective To determine the effect of duloxetine, 60 mg daily, on average …
Immune response in patients with newly diagnosed glioblastoma multiforme treated with intranodal autologous tumor lysate-dendritic cell vaccination after radiation …
CE Fadul, JL Fisher, TH Hampton… - Journal of …, 2011 - journals.lww.com
Patients with glioblastoma multiforme (GBM) are profoundly immunosuppressed and may
benefit from restoration of an antitumor immune response in combination with conventional …
benefit from restoration of an antitumor immune response in combination with conventional …
Recurrent meningioma: salvage therapy with long-acting somatostatin analogue
MC Chamberlain, MJ Glantz, CE Fadul - Neurology, 2007 - AAN Enterprises
… Fadul has nothing to disclose. … Fisher R, Fadul C, Chamberlain MC, et al. Potential efficacy
of somatostatin for treatment of recurrent meningiomas. Neurology 2006;66:A330. … Fadul, MD …
of somatostatin for treatment of recurrent meningiomas. Neurology 2006;66:A330. … Fadul, MD …
Long-term response of pituitary carcinoma to temozolomide: report of two cases
CE Fadul, AL Kominsky, LP Meyer, LS Kingman… - Journal of …, 2006 - thejns.org
✓Pituitary carcinoma is a rare tumor characterized by poor responsiveness to therapy, leading
to early death. Reported responses to standard chemotherapy have only been anecdotal, …
to early death. Reported responses to standard chemotherapy have only been anecdotal, …
Immune modulation effects of concomitant temozolomide and radiation therapy on peripheral blood mononuclear cells in patients with glioblastoma multiforme
CE Fadul, JL Fisher, J Gui, TH Hampton… - Neuro …, 2011 - academic.oup.com
Concomitant radiation therapy (RT) and temozolomide (TMZ) therapy after surgery is the
standard treatment for glioblastoma multiforme (GBM). Radiation and chemotherapy can affect …
standard treatment for glioblastoma multiforme (GBM). Radiation and chemotherapy can affect …
Brain metastases from colorectal cancer: risk factors, incidence, and the possible role of chemokines
JP Mongan, CE Fadul, BF Cole, BI Zaki… - Clinical colorectal …, 2009 - Elsevier
Background Brain metastases from colorectal cancer (CRC) are uncommon. There has
been relatively little published on the host and tumor factors that might lead to this clinical …
been relatively little published on the host and tumor factors that might lead to this clinical …
Anti-VEGF therapy in pituitary carcinoma
…, LV Syro, BW Scheithauer, A Ersen, H Uribe, CE Fadul… - Pituitary, 2012 - Springer
We report the case of a 44-year-old male patient with an aggressive silent corticotroph cell
pituitary adenoma, subtype 2. In that it progressed to carcinoma despite temozolomide …
pituitary adenoma, subtype 2. In that it progressed to carcinoma despite temozolomide …
[HTML][HTML] 5-Hydroxymethylcytosine localizes to enhancer elements and is associated with survival in glioblastoma patients
…, JE King, KM Von Herrmann, CE Fadul… - Nature …, 2016 - nature.com
Glioblastomas exhibit widespread molecular alterations including a highly distorted
epigenome. Here, we resolve genome-wide 5-methylcytosine and 5-hydroxymethylcytosine in …
epigenome. Here, we resolve genome-wide 5-methylcytosine and 5-hydroxymethylcytosine in …
Postoperative stereotactic radiosurgery without whole-brain radiation therapy for brain metastases: potential role of preoperative tumor size
…, AJ Paravati, WJ Spire, Z Li, LA Jarvis, CE Fadul… - International Journal of …, 2013 - Elsevier
PURPOSE: Radiation therapy following resection of a brain metastasis increases the probability
of disease control at the surgical site. We analyzed our experience with postoperative …
of disease control at the surgical site. We analyzed our experience with postoperative …
Stereotactic radiosurgery with and without checkpoint inhibition for patients with metastatic non–small cell lung cancer to the brain: a matched cohort study
…, N Mohammed, RD Gentzler, J Larner, CE Fadul… - Journal of …, 2019 - thejns.org
OBJECTIVE Immune checkpoint inhibitors (ICIs) improve survival in patients with advanced
non–small cell lung cancer (NSCLC). Clinical trials examining the efficacy of ICIs in patients …
non–small cell lung cancer (NSCLC). Clinical trials examining the efficacy of ICIs in patients …
